Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from iex and EODHD
Download Data

Arcadia Biosciences Inc Income Statement 2012 - 2023

This table shows the Income Statement for Arcadia Biosciences Inc going from 2012 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31
Revenue
M 5 10 7 8 1 1 4 3 5 7 6 7
Cost of Revenue
M 3 10 9 5 1 1 0 1 1 2 1 1
Gross Profit
M 2 0 -2 3 0 1 4 2 5 5 6 6
Operating Expenses
M 16 20 34 24 21 18 18 21 20 20 16 16
Selling, General, and Administrative Expenses (SG&A)
M 18 18 23 16 14 12 11 12 11 10 8 8
Research and Development (R&D) Expenses
M 1 2 4 8 7 6 7 9 9 10 8 8
Other Operating Expenses
M -3 0 7 0 0 0 0 0 0 0 0 0
Costs and Expenses
M 13 10 18 19 20 17 18 20 19 18 16 15
Operating Income
M -14 -19 -36 -22 -20 -17 -14 -19 -16 -15 -11 -10
Interest Expense
M - 0 0 0 0 0 1 1 3 1 1 0
Non-operating Income/Expense
M 1 4 19 15 -8 6 -1 0 0 -1 0 0
EBT
M -13 -16 -16 -6 -29 -13 -16 -20 -18 -17 -11 -10
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -13 -16 -16 -6 -29 -13 -16 -20 -18 -17 -11 -11
Non-Controlling Interest
M - - -1 -1 1 7 0 0 3 4 - -
Net Income
M - - -15 -5 -29 -13 -16 -20 -21 -22 - -
Shares (Basic, Weighted)
M - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 1,236,934.00 599,389.00 532,015.00 248,975.00 159,077.00 94,160.00 53,905.00 55,458.00 35,698.00 40,900.00 40,900.00 40,900.00
EBITDA
M -13 -23 -18 -21 -20 -23 -14 -18 -15 -15 -10 -10
Depreciation and Amortization
M 1 -3 17 1 0 0 0 0 0 0 0 0
EBIT
M -14 -19 -36 -22 -20 -23 -14 -18 -15 -15 -11 -10
Income from Discontinued Operations
M - - - - - - - - - - - -
Tax Rate (Effective)
% -0.06 -0.09 -0.01 2.02 -0.01 -0.07 -0.17 -0.13 -0.15 -1.53 -1.49 -2.07
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 - -
Gross Profit Margin
% 38.09 1.55 -28.44 35.29 24.29 54.85 92.97 71.93 83.52 71.40 89.61 87.03
Operating Income Margin
% -260.13 -194.89 -523.98 -268.76 -1,743.46 -1,152.32 -355.56 -584.07 -287.46 -217.03 -163.11 -144.51
Net Income Margin
% - - -216.22 -57.94 -2,464.07 -920.77 -390.14 -615.56 -382.84 -316.20 - -
EBITDA Ratio
% -241.67 -228.21 -270.87 -259.21 -1,747.56 -1,562.64 -341.65 -563.86 -272.40 -211.90 -156.99 -139.00
EBIT Ratio
% -260.13 -194.89 -523.98 -268.76 -1,743.46 -1,573.16 -348.58 -573.40 -277.84 -217.03 -163.03 -144.39
EBT Ratio
% -246.85 -156.67 -237.94 -76.55 -2,469.72 -920.08 -389.49 -614.77 -331.18 -245.55 -172.69 -147.05

StockViz Staff

September 16, 2024

Any question? Send us an email